NIH-funded research NIH-funded research

Understanding KIF1A-related neurological disease

Official title: Interrogation of Neurological Pathologies Associated with Mutations in Kif1a

Funded at Jackson Laboratory · NIH-11392450 · Data updated 2026-11-12

This project builds mouse models of KIF1A-related neurological disorder to help develop treatments for children and adults with KAND.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionJackson Laboratory
NIH-funded
Lab location1 site (Bar Harbor, United States)
Project startSeptember 1, 2023
Project endFebruary 28, 2027
Funding year2026
Award (this year)$433,867
NIH project number5R33NS133266-04
Project IDNIH-11392450 on NIH RePORTER

Who could benefit from this research

Could help

Children and adults diagnosed with KIF1A-associated neurological disorder (KAND) or families affected by KIF1A mutations are the population most likely to benefit from therapies guided by this work.

Less likely to help

People without KIF1A mutations or with unrelated neurological conditions are unlikely to receive direct benefit from this project.

What this research studies

If you or your child has KAND, this project will create mouse versions of the disease that mimic the symptoms people experience. Scientists will use these mouse models to test when treatments need to be given, whether adding extra copies of the gene helps, which brain or nerve cell types must be fixed, and how much genetic correction is needed to change the disease. The mice will also be used to test potential drugs or genetic therapies before they are considered for people. Results are intended to guide safer and more effective clinical trials for children and adults with KIF1A mutations.

Why it matters

Potential benefit: Could speed development of effective therapies and clarify when and how treatments must be given to slow or prevent KAND progression.

How similar studies have gone: Using mouse models to guide genetic-disease therapies is a common translational approach, but KIF1A-specific models are currently limited, so this work addresses an unmet need.

Where this research is happening

  • Jackson Laboratory
    Bar Harbor, United States
    Active

Researchers

  • Principal investigator: Lutz, Cathleen M — Jackson Laboratory
  • Study coordinator: Lutz, Cathleen M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.